We work with different types of communication to spread information, and raise awareness about initiatives, people and organizations. Would you like us to help you to reach out with information? Please get in touch!
"Life science is an international sport"
In Almedalen, the seminar "Life science clusters in Sweden - why?" was fully booked. The importance of collaboration, and seeing Sweden as a single cluster was highlighted by several speakers in the panel. More knowledge as well as greater value for customers and patients are some of the benefits.
Available job: Project Manager
Stockholm Science City Foundation is looking for a Project Manager who can participate in developing the life science hub emerging in Hagastaden. For a world-leading position to become an area for life science, collaboration between universities, health care and industry must be strengthened.
AstraZeneca – now in Hagastaden
The vision for Hagastaden in 2007 was to develop and strengthen the area into a world-class life science cluster. One of the industry representatives then was AstraZeneca's global research manager. Their new head office is now in Hagastaden, linking the vision with one of Sweden's most important life science companies.
"We want more doctors to continue research after their dissertations"
Tobias Alfvén works as a pediatrician at Sachsska Children's and Youth Hospital, and research as an associate professor at the Department of Global Public Health at Karolinska Institutet. He is president of the “lively 200-year-old organization” the Swedish Society of Medicine/Svenska Läkaresällskapet. He also tells about their new report regarding medical and health science research.
EpiEndo expands operations with new facility in Hagastaden
EpiEndo is developing new anti-inflammatory, barrier-strengthening drugs for the treatment of chronic respiratory diseases, with a focus on chronic obstructive pulmonary disease (COPD). A successful Phase I study was recently completed and several clinical studies are underway.
Pfizer chooses Hagastaden
Pfizer will move the Swedish headquarters to Life City in the beginning of 2023. Malin Parkler, CEO at Pfizer Sweden, explains what it means for Pfizer to move to an area with so many stakeholders within life science, and what the move means for other companies in Hagastaden.
To be in a lifelong learning
After I graduated from high school in the 90's, I was fed up with school and had a hard time seeing myself continue to study. In addition, I managed to make a career very early and was headhunted between the companies. This made me feel that studies were not a necessity.
The universities' collaboration on health
Many societal challenges are so complex that they cannot be solved on their own. Partnership and cooperation are necessary to achieve the global goals - and here the academy plays an important role. During the World Academic Forum on May 19, Karolinska Institutet, KTH Royal Institute of Technology and Stockholm University told how they mobilize to improve human and planetary health.
Stockholm will be an even stronger meeting place
The project "Attraktion Stockholm" aims to develop new ways to promote collaboration and attract more international academic meetings to Stockholm. It is a collaborative project between the city of Stockholm, the three universities in Stockholm and the business community.
Visualization of gene activity in tissue with potential for completely new diagnostics
Alzheimer's, ALS and cancer are diseases in which the new methodology Spatial Transcriptomics becomes an important tool. Joakim Lundeberg and Patrik Ståhl form KTH, have together with Jonas Frisén from Karolinska Institutet developed the methodology.
Albano - unique environment for research and education
The new university area Albano is close to both Stockholm University (SU) and KTH, and not far from the centre of town. The area offers an attractive environment for research and education. It connects mainly SU and KTH, but also the two universities with the city. This hub will strengthen Stockholm as a city of knowledge
The implementation of precision medicine requires structures and cooperation on several levels
In Sweden, a national infrastructure for precision medicine – Genomic Medicine Sweden (GMS) was established five years ago. One of the objectives for GMS is to strengthen Swedish healthcare through a coordinated implementation of broad gene analysis for improved diagnostics, treatment, and follow-up, of patients with a variety of diseases across the country.
Conditions for life science companies in Sweden: recorded seminar
What are the chances for running and developing companies in life science in Sweden today? Which financing options are suitable for different companies? When should you start planning for different exit strategies? How can a small company plan when it comes to partnerships and possible acquisitions?
Almost 50 % increase in ten years
Between 2009 and 2019, the number of life science companies in the Stockholm-Uppsala region increased by almost 50%. This is stated in a report published by the Stockholm Science City Foundation on the 31 of March. Half of the employees within Sweden's life science work in the region, which means 31,500 people at nearly 1,000 companies. The report also shows that half of Sweden's patent applications originate from the region.
Research!Sweden is working to strengthen medical research for health
Research!Sweden's vision is that medical research and business continue to develop in, or move to, Sweden and that advancement of medicine reaches the general public at a faster rate. The Secretary General Anna Nilsson Vindefjärd with colleagues continue the work with this as a guiding light together with many committed partners, both in the life science system, the patient organizations and in politics.